
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. (CRVS)
WebsitePrice
Market cap
Next catalystCohort 2 enrollment planned to begin in late November 2026Soquelitinib — Angel Pharma China Phase 1b/2 · Trial initiationCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
Other pipelines
Partner / License out
PreINDP1P3FilingApproved
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved